首页|期刊导航|世界中医药|降酶退黄合剂治疗急性肝损伤的作用机制研究

降酶退黄合剂治疗急性肝损伤的作用机制研究OACHSSCD

Mechanisms of Jiangmei Tuihuang Mixture in Treating Acute Liver Injury

中文摘要英文摘要

目的:基于微小核糖核酸103/磷酸酶及张力蛋白磷酸酶同源物/内质网应激(miRNA103/PTEN/ERS)信号通路探讨降酶退黄合剂(JTM)对急性肝损伤动物模型肝细胞的保护作用及机制.方法:选择人肝细胞系5(HHL-5),常规传代培养,分别分为空白组、模型组、JTM组、微小核糖核酸-103-3p抑制剂空载组(miR-103-3p inhibitor-NC组)、微小核糖核酸-103-3p 抑制剂组(miR-103-3p inhibitor 组)、微小核糖核酸-103-3p 抑制剂+JTM 组(miR-103-3p inhibitor+JTM 组).制备JTM含药血清,采用细胞计数试剂盒-8(CCK-8)法筛选出最佳药物浓度和作用时间对上述细胞进行干预;采用蛋白质印迹法(WB)及定量逆转录-聚合酶链反应(qRT-PCR)法检测HHL-5细胞miR-103-3p及PTEN/ERS信号通路相关分子的蛋白、mRNA的表达.结果:与空白组比较,模型组的miRNA-103-3p及PTEN/ERS信号通路相关分子mRNA、蛋白表达均升高(P<0.05).与模型组比较,JTM 组、miRNA-103-3p inhibitor+JTM 组 miRNA-103-3p、PTEN、葡萄糖调节蛋白 78(GRP78)、蛋白激酶R样内质网激酶(PERK)、活化转录因子4(ATF4)、C/EBP同源蛋白(CHOP)、活化转录因子6(ATF6)、磷酸化-肌醇需求激酶1(p-IRE1)和X-盒结合蛋白1(XBP-1)mRNA表达降低,尤以miRNA-103-3p inhibitor+JTM组最为显著(P<0.01);PTEN、GRP78、PERK、ATF4、CHOP、ATF6、p-IRE1、XBP-1 蛋白表达降低,尤以 miRNA-103-3p inhibi-tor+JTM 组显著(P<0.05).结论:JTM可通过下调急性肝损伤大鼠肝细胞内miRNA-103-3p表达,阻断PTEN/ERS信号转导,阻止内质网功能紊乱,从而达到保肝护肝的作用.

Objective:To investigate the protective effects and mechanisms of Jiangmei Tuihuang Mixture(JTM)on hepatocytes in an acute liver injury model based on the miRNA-103/phosphatase and tensin homolog(PTEN)/endoplasmic reticulum stress(ERS)signaling pathway.Methods:Human hepatocyte cell line HHL-5 was routinely cultured and divided into a blank group,a model group,a JTM group,a miR-103-3p inhibitor negative control(NC)group,a miR-103-3p inhibitor group,and a miR-103-3p inhibitor+JTM group.JTM-containing serum was prepared.The CCK-8 assay was used to determine the optimal drug concentration and exposure time for intervention.Western blot(WB)and quantitative reverse transcription-polymerase chain reaction(qRT-PCR)were used to detect the mRNA and protein expression levels of miR-103-3p and PTEN/ERS pathway-related molecules in HHL-5 cells.Results:Compared with the blank group,the model group showed significantly increased mRNA and protein expression levels of miR-103-3p and PTEN/ERS pathway-related molecules(P<0.05).Compared with the model group,the JTM group and the miR-103-3p inhibitor+JTM group showed decreased mRNA expression levels of miR-103-3p,PTEN,glucose-regulated protein 78(GRP78),protein kinase R-like endoplasmic reticulum kinase(PERK),activating transcription factor 4(ATF4),C/EBP homolo-gous protein(CHOP),activating transcription factor 6(ATF6),phosphorylated inositol-requiring enzyme 1(p-IREl),and X-box binding protein 1(XBP-1),with the most significant effect observed in the miR-103-3p inhibitor+JTM group(P<0.01).Protein expression levels of PTEN,GRP78,PERK,ATF4,CHOP,ATF6,p-IREl,and XBP-1 were also decreased,with the miR-103-3p in-hibitor+JTM group showing a more significant effect(P<0.05).Conclusion:JTM can exert hepatoprotective effects by downregu-lating miR-103-3p expression in hepatocytes with acute liver injury,thereby blocking PTEN/ERS signal transduction,preventing endoplasmic reticulum dysfunction,and ultimately protecting liver function.

程玲;张琦;李魏;魏连波;程怀东

广州中医药大学深圳医院[福田]肿瘤科,深圳,518000||安徽中医药大学第一附属医院重症医学科,合肥,230031||南方医科大学深圳医院中医科,深圳,518100安徽中医药大学第一附属医院肝胆外科,合肥,230031安徽中医药大学第一附属医院重症医学科,合肥,230031南方医科大学深圳医院中医科,深圳,518100南方医科大学深圳医院肿瘤科,深圳,518100

医药卫生

降酶退黄合剂急性肝损伤微小核糖核酸-103磷酸酶及张力蛋白磷酸酶同源物内质网应激信号通路内质网细胞凋亡

Jiangmei Tuihuang MixtureAcute liver injuryMiRNA103PTENERSSignaling pathwayEndoplasmic reticu-lumApoptosis

《世界中医药》 2026 (4)

623-628,635,7

国家自然科学基金项目(82274251)安徽省卫生健康科研项目(AHWJ2023A20149)安徽省新时代育人质量工程(研究生教育)项目(2024zyxwjxalk116)深圳市科技计划项目(JCYJ20220530154203007)南方医科大学2024年腾飞计划项目(23H3ATF01)安徽中医药大学临床科研项目(2021yfylc04).

10.3969/j.issn.1673-7202.2026.04.007

评论